MX2020011741A - Método para controlar la evolución del hiperparatiroidismo mediante calcifediol, y composiciones para usarse en el mismo. - Google Patents
Método para controlar la evolución del hiperparatiroidismo mediante calcifediol, y composiciones para usarse en el mismo.Info
- Publication number
- MX2020011741A MX2020011741A MX2020011741A MX2020011741A MX2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A MX 2020011741 A MX2020011741 A MX 2020011741A
- Authority
- MX
- Mexico
- Prior art keywords
- hyperparathyroidism
- compositions
- controlling
- calcifediol
- evolution
- Prior art date
Links
- 201000002980 Hyperparathyroidism Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 title 1
- 235000021318 Calcifediol Nutrition 0.000 title 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 title 1
- 229960004361 calcifediol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802148P | 2019-02-06 | 2019-02-06 | |
| PCT/IB2020/000089 WO2020161543A1 (en) | 2019-02-06 | 2020-02-06 | Method of controlling progression of hyperparathyroidism with calcifediol, and compositions for use therein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020011741A true MX2020011741A (es) | 2021-03-02 |
Family
ID=69903711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020011741A MX2020011741A (es) | 2019-02-06 | 2020-02-06 | Método para controlar la evolución del hiperparatiroidismo mediante calcifediol, y composiciones para usarse en el mismo. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220226351A1 (enExample) |
| EP (1) | EP3920938A1 (enExample) |
| JP (2) | JP2022519789A (enExample) |
| KR (1) | KR20210126023A (enExample) |
| CN (1) | CN113573714A (enExample) |
| AU (2) | AU2020218639A1 (enExample) |
| CA (1) | CA3128153A1 (enExample) |
| MX (1) | MX2020011741A (enExample) |
| WO (1) | WO2020161543A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2640094C (en) | 2006-02-03 | 2015-04-14 | Proventiv Therapeutics, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| PL2679228T3 (pl) | 2006-06-21 | 2018-07-31 | Opko Ireland Global Holdings, Ltd. | Terapia z użyciem środka do uzupełniania witaminy D i środka do zastępowania hormonami witaminy D |
| KR101495578B1 (ko) | 2007-04-25 | 2015-02-25 | 사이토크로마 인코포레이티드 | 비타민 ｄ 부족 및 결핍의 치료 방법 |
| SI2481400T1 (sl) * | 2007-04-25 | 2014-11-28 | Opko IP Holdings II, Inc. | Nadzorovano oralno sproščanje sestavkov, ki vsebujejo spojino vitamina D in voskasti nosilec |
| FI3225243T3 (fi) | 2007-04-25 | 2025-10-13 | Opko Renal Llc | Menetelmä sekundaarisen hyperparatyreoosin turvalliseen ja tehokkaaseen hoitoon ja ehkäisyyn kroonisen munuaistaudin yhteydessä |
| EP3112476B1 (en) | 2008-04-02 | 2023-08-02 | EirGen Pharma Ltd. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
| AU2013203489B2 (en) * | 2008-07-24 | 2015-02-05 | Wisconsin Alumni Research Foundation | Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration |
| EP3636280B1 (en) * | 2010-03-29 | 2025-05-14 | EirGen Pharma Ltd. | Methods and compositions for reducing parathyroid levels |
| KR101847947B1 (ko) * | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) * | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| SG10201913863TA (en) * | 2016-03-28 | 2020-03-30 | Opko Ireland Global Holdings Limited | Methods of vitamin d treatment |
| JP7590184B2 (ja) * | 2018-04-03 | 2024-11-26 | オプコ アイルランド グローバル ホールディングス リミテッド | 肥満外科手術患者におけるカルシフェジオールの使用 |
-
2020
- 2020-02-06 EP EP20713085.7A patent/EP3920938A1/en active Pending
- 2020-02-06 KR KR1020217026559A patent/KR20210126023A/ko not_active Ceased
- 2020-02-06 MX MX2020011741A patent/MX2020011741A/es unknown
- 2020-02-06 JP JP2021569596A patent/JP2022519789A/ja active Pending
- 2020-02-06 US US17/429,278 patent/US20220226351A1/en active Pending
- 2020-02-06 CN CN202080020844.6A patent/CN113573714A/zh active Pending
- 2020-02-06 AU AU2020218639A patent/AU2020218639A1/en not_active Abandoned
- 2020-02-06 WO PCT/IB2020/000089 patent/WO2020161543A1/en not_active Ceased
- 2020-02-06 CA CA3128153A patent/CA3128153A1/en active Pending
-
2024
- 2024-11-25 JP JP2024204631A patent/JP2025031720A/ja active Pending
-
2025
- 2025-10-30 AU AU2025259887A patent/AU2025259887A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020161543A1 (en) | 2020-08-13 |
| CN113573714A (zh) | 2021-10-29 |
| EP3920938A1 (en) | 2021-12-15 |
| CA3128153A1 (en) | 2020-08-13 |
| JP2022519789A (ja) | 2022-03-24 |
| KR20210126023A (ko) | 2021-10-19 |
| US20220226351A1 (en) | 2022-07-21 |
| JP2025031720A (ja) | 2025-03-07 |
| AU2020218639A1 (en) | 2021-08-12 |
| AU2025259887A1 (en) | 2025-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202102549B (en) | Substituted tolyl as fungicides | |
| CO2020016619A2 (es) | Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso | |
| LT3814348T (lt) | Pakeistieji naftiridinono junginiai, naudotini kaip t ląstelių aktyvatoriai | |
| MX2023007841A (es) | Metodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cancer. | |
| UY36730A (es) | Fenoxifenilamidinas sustituidas con halógeno y el uso de estas como fungicidas | |
| MX2019007030A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| CL2019002792A1 (es) | Composición para producir tagatosa y procedimiento de producción de tagatosa usando el mismo. | |
| BR112017003414A2 (pt) | composições compreendendo caseína e métodos para produzir as mesmas | |
| BR112018006696A2 (pt) | métodos e sistemas para obter óleo a partir de uma composição de vinhoto | |
| MX2019011758A (es) | Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma. | |
| MX2018000880A (es) | Inhibidores del receptor del factor estimulante de colonias 1 (csf-1r). | |
| MX2020003605A (es) | Manipulación del metabolismo de triptamina. | |
| MX2019012352A (es) | Composiciones, sistemas, kits y metodos para ablacion neural. | |
| BR112019020338A8 (pt) | Composição para produção de tagatose, e, método de produção de tagatose | |
| MX2019010492A (es) | Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado. | |
| IL251616B (en) | Methods and compounds for the treatment and prevention of muscle mass loss | |
| MX378235B (es) | Métodos para mejora hidráulica de cultivos. | |
| DK3897157T3 (da) | Plantvækstfremmersammensætning, fremgangsmåder til fremstilling heraf og anvendelser deraf | |
| EA201791233A1 (ru) | Материал стволовых клеток и способ его получения | |
| BR112018009097A2 (pt) | spodoptera frugiperda resistente a vip3a | |
| EA201892368A1 (ru) | ИНГИБИТОРЫ ErbB И ИХ ПРИМЕНЕНИЕ | |
| EA202090732A1 (ru) | Составы для трансдермального введения | |
| MY176584A (en) | Gluconate repressor variant, microorganism containing the same producing l-lysine, and method for producing l-lysine | |
| MX390050B (es) | Composiciones para el cuidado personal | |
| TR201903795T4 (tr) | Ngs si̇stemleri̇ kontrolü ve bunu kapsayan yöntemler |